In this trial, 342 men with sildenafil-failure ED were given either intranasal PT-141 (10 mg dose) or placebo on demand over ~48 weeks.The outcomes demonstrated a clear benefit of bremelanotide: About 33.5% of men on bremelanotide achieved a positive clinical response (improved erections sufficient for intercourse) compared to only 8.5% on placebo
Mansour A, Mohajeri-Tehrani MR, Qorbani M, Heshmat R, Larijani B, Hosseini S
Once approved, you generally wont need another prior authorization for refills or dose changes through December 31, 2027
Drug Des Devel Ther 14:38153826
(2006) Migraine, fibromyalgia, and depression among people with IBS: a prevalence study
In the initial dose-finding studies, three concentrations of Cagrilintide ranging from 3, 30, and 300 nmol/kg, were tested in chow-fed WT mice